Document is current
Any future updates will be listed below
-
Authors
Harr, Thomas J.
Gupta, Nikesh
Rahar, Babita
Stott, Kristen
Medina-Guevara, Yadira
Gari, Metti K.
Oler, Angie T.
McDermott, Ivy Sohee
Lee, Hye Jin
Rasoulianboroujeni, Morteza
Weichmann, Ashley M.
Forati, Amir
Holbert, Kelsey
Langel, Trevor S.
Coulter, Kade W.
Burkel, Brian M.
Tomasini-Johansson, Bianca R.
Ponik, Suzanne M.
Engle, Jonathan W.
Hernandez, Reinier
Kwon, Glen S.
Sandbo, Nathan
Bernau, Ksenija
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-22-1-0692, W81XWH1910285, HT94252410543)
National Heart, Lung, and Blood Institute (K01HL171464, R01HL146402)
American Heart Association (24CDA1272732, 24CDA1272732)
Pulmonary Fibrosis Foundation (1053163, 1053163)
National Cancer Institute (R01CA257837, R01CA206458, U54CA268069, P30CA014520)
Dr. Ralph and Marian Falk Medical Research Trust (Falk Transformational Award)
University of Wisconsin-Madison (Trewartha Senior Thesis Research Award, Honors Summer Senior Thesis Research Grant Award)
- License Information
-
More Information
Article History
Received: 14 November 2024
Accepted: 7 January 2025
First Online: 22 January 2025
Declarations
:
: Animal studies were approved by the University of Wisconsin-Madison IACUC (protocol numbers M005823 and M005532). No human subjects or tissues were used in this work.
: BRTJ, GSK, NS, and KB are inventors on an issued patent application (pub. no. US10828372B2; date of application granted: 10 November 2020) held by Wisconsin Alumni Research Foundation that covers the PEGylation of FN-binding peptides and their application in fibrosis. RH is a consultant to Archeus Technologies Inc. and MonoPar Therapeutics Inc. He is a member of the science advisory board of Archeus. None of these activities have any relation to imaging of pulmonary fibrosis. All other authors declare that they have no competing interests.
